In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
486 News Items found
DNA molecules wrapped around histones
Feature
The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Joan Massagué
How Cancer Spreads: Four Emerging Insights About Metastasis

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
Pictured: Joan Massagué
Cancer Biologist Joan Massagué Honored on Two Continents

Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.
Scientist Gabriela Chiosis in her lab
In the Lab
Experimental Drug Targets Misbehaving Proteins in Brain Cancer and Alzheimer’s Disease

Memorial Sloan Kettering researchers are studying how drugs that reverse malfunctioning proteins may treat disease.
Portrait of a live zebrafish with dark patterning around and above the eyes
In the Lab
Uncharted Waters: The Making of a New Cancer Drug

A team of scientists is combining sophisticated chemistry and experiments in zebrafish to develop a new cancer drug that shows early potential against melanoma and metastatic breast cancer.
MSK gastroenterologist Robin Mendelsohn seen smiling at desk.
How Does an At-Home Colorectal Cancer Screening Test Compare to a Colonoscopy? Answers From an Expert at Memorial Sloan Kettering Cancer Center

Learn about the difference methods of colorectal cancer screening, including the at-home Cologuard test, from an expert at Memorial Sloan Kettering Cancer Center.
Memorial Sloan Kettering medical oncologist Dean Bajorin
Q&A
Immunotherapy Drug Lowers Risk of Bladder Cancer Returning after Surgery

People with bladder cancer may soon have a new treatment option following surgery.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach

The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
An MSK patient and advocate for people working with cancer, Gina Jacobson looks relaxed and smiles at the camera, with her left hand under her chin.
Working When You Have Cancer

After a cancer diagnosis, one of the first and toughest decisions people face is how much to share in the workplace. Read more about working with cancer — and how MSK offers guidance and support.
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.